
    
      The overall objective is to conduct a double-blind, randomized, placebo-controlled, parallel
      group trial to determine the efficacy of 6 months of physiological testosterone replacement
      therapy in improving cancer related fatigue, sexual dysfunction, and body composition and
      muscle function in men 60 years and older with active lung or colorectal cancers, who report
      fatigue and have testosterone deficiency.There will be 5 study visits: 1) Screening, 2)
      Baseline, 3) 2-Week Dose Adjustment Visit, 4) Three-month visit (Week 12), and 5) Six-month
      visit. Testosterone or placebo gels will be applied by eligible trial participants at home;
      participants will be trained on gel application procedures by research personnel.
    
  